SAMUEL BENNETT: Open Payments
NPI 1255192944 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,065 in 156 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $2,505 · 2025 $3,065
Food & beverage: $2,904Education: $161
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $575 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 28 | $514 |
| Janssen Biotech, Inc. | 13 | $311 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $246 |
| Madrigal Pharmaceuticals | 11 | $225 |
| Regeneron Healthcare Solutions, Inc. | 8 | $220 |
| GENZYME CORPORATION | 6 | $163 |
| Ardelyx, Inc. | 10 | $139 |
| QOL Medical, LLC | 4 | $125 |
| PFIZER INC. | 5 | $93 |
Products named: XIFAXAN, DUPIXENT, TREMFYA, RINVOQ, REZDIFFRA, ENTYVIO, LINZESS, IBSRELA.
Industry payments across GA — which companies pay providers there.
